Breast Cancer: The Evolution in Breast Biopsy, Surgery, and Brachytherapy
Advances in breast cancer screening are making earlier detection the norm, but biopsy devices are progressing as well. Emerging technologies, along with a number of new oncolytic drugs, will add add to the growing treatment armamentarium for breast cancer.
You may also be interested in...
Frontiers in Breast Cancer Research, Part II: Developments in Partial Breast Irradiation and Tumor Ablation
As the use of breast conserving lumpectomy expands as a treatment for early-stage breast cancer, interest has surged in alternatives to whole breast irradiation. Follow-on radiation treatment is crucial to the success of this therapy, but a significant number of women are either unable or unwilling to undergo the typical treatment course involving five to seven weeks of daily radiation therapy. The device industry is responding with technologies aimed at delivering post-lumpectomy radiation therapy in a more convenient, potentially safer way.
All cancer treatments-- surgery, chemotherapy and radiation therapy-carry the risk of adverse effects or the need for adjuvant therapies. With two-thirds of all cancer patients today receiving radiation therapy and a significant number undergoing invasive therapies such as surgery, Actuality Medical is developing technology for improving the precision, morbidity, and quality of radiation oncology and surgical excision for soft tissue applications, starting with prostate and breast cancer.
Breast cancer is the most common type of female cancer and the number two cancer killer in US women. Treatment options continue to expand and researchers are making steady advancements in cancer detection that they hope will one day enable most breast cancer cases to be diagnosed an an early, very curable stage.